Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
Athenex, Inc.

Athenex, Inc. (ATNX) Stock Overview

Explore Athenex, Inc.’s financial performance, market position, analyst ratings, and future outlook.

ATNX●NASDAQ
HealthcareDrug Manufacturers - Specialty & Generic
$0.20
$0.00(0.00%)
U.S. Market is Open · 13:56

Athenex, Inc. (ATNX)

Meyka AI Score

Z

Key Financials

Market Cap2.3M
P/E Ratio-0.01
EPS (TTM)$-10.45
ROE0.22%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

ATNX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of Athenex, Inc. (NASDAQ: ATNX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B, Athenex, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of ATNX on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind Athenex, Inc.'s NASDAQ-traded stock include a P/E ratio of -0.01 and a market capitalization of 2.3M. Combined with our AI analysis, these give both institutional and retail investors a clear view of ATNX on the NASDAQ.

Price Performance (NASDAQ: ATNX)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-23.39%
3-Month Change
-84.38%
6-Month Change
-93.44%
Year-to-Date (YTD) Change
-94.16%
1-Year Change
-98.12%
3-Year Change
-99.92%
5-Year Change
-99.95%
All-Time (Max) Change
-99.92%

Contact Information

https://www.athenex.com
716 427 2950
Conventus Building, Buffalo, NY, 14203

Company Facts

2,690 Employees
IPO DateJun 14, 2017
CountryUS

Frequently Asked Questions